ResearcherFirst Affiliated Hospital of Zhengzhou UniversityActive in the last 2 years
Wenhao Mao
Matched on OpenAlex author ID A5074679751. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of Anti-PD-1 immunotherapy. Co-author DOI 10.1038/s41419-025-07550-y↗
- Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer. Co-author DOI 10.7150/ijbs.61795↗
- YAP in pancreatic cancer: oncogenic role and therapeutic strategy. Co-author DOI 10.7150/thno.53438↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ting Sun · 3 shared papers, 2021–2025 · strength 0.57
- Paper TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of Anti-PD-1 immunotherapy. DOI 10.1038/s41419-025-07550-y↗
- Paper YAP in pancreatic cancer: oncogenic role and therapeutic strategy. DOI 10.7150/thno.53438↗
- Paper Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer. DOI 10.7150/ijbs.61795↗
- Lin Jiao · 2 shared papers, 2021–2025 · strength 0.39
- Jia Mai · 2 shared papers, 2021 · strength 0.32
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.